event-trade登录编辑
PR Newswire All News ReleasesQwen · 实盘不做把握 9/10不做原因:不是事件
北京时间·🕒 发布 14:54:00·⟳ 抓取 14:54:22 +22s·⚡ 决策 08-31 20:29:17 +5h34m·57.2 天前

律所 Schall Brown & Schwartz 发布 Insulet(PODD)证券集体诉讼首席原告截止日提醒广告

本条信号是律所 Schall Brown & Schwartz 在首席原告截止日(2026-08-31)发布的招募广告,不含任何关于 Insulet 的新增事实、新监管动作或新信息。所涉指控(制造过程控制缺陷、2026年3月医疗器械纠正影响范围超预期)均为数月前的旧闻,集体诉讼期间已于 2026-05-26 结束。律所广告不构成可交易的股价催化剂,无可执行的交易方向。

📄 原文PR Newswire All News Releases↗ 原文
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit LOS…
不做 Insulet Corporation(PODD.US)
本条信号为律所首席原告招募广告,不含任何新增事实。底层指控(制造缺陷、2026年3月医疗器械纠正)均为数月旧闻,集体诉讼期间已于 2026-05-26 结束。律所广告不构成股价催化,无方向性交易机会。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

Insulet(PODD) 收到律所证券欺诈集体诉讼首席原告招募广告。该广告仅是截止日提醒,不含新增事实。底层事件(制造缺陷、2026年3月医疗器械纠正)均为旧闻,集体诉讼期间已于 2026-05-26 结束。律所广告在美股市场极为常见,不构成股价催化,无可交易方向。

🔎 新鲜度:最早出现 2026-08-31 · 扩散 low · price-in 风险 low ↗

先例如何影响了这次决策

对本次决策的影响:无先例可用,因本事件不构成可交易催化

方向:不适用——律所广告不构成可交易催化,无需先例校准

涨幅量级:不适用

形态:不适用

工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
  1. search_processed_events 成功 stock_tools HTTP · 270 ms
    {"result": "search_processed_events:agent query=`insulet manufacturing defect class action | insulet medical device correction 2026 | insulet podd securities fraud lawsuit`;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 71.2/72 小时、1063 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选,不能据此证明消息首发或不是重复;按当前事件继续正常研判。"}

原文全文

展开原文 · 3,093 字
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ: PODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
If you purchased Insulet Corporation securities you may be entitled to compensation without payment of any out-of-pocket fees or costs. Shareholders who purchased shares of PODD during the class period listed are encouraged to contact SBS to find out if they are eligible to recover their losses or lead this lawsuit. Appointment as lead plaintiff is not required to partake in any recovery. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
CLASS PERIOD: February 21, 2025 to May 26, 2026
DEADLINE: August 31, 2026
If you are a shareholder who suffered a loss, click here to participate.
Details of the Case: According to the Complaint, the Company made false and misleading statements to the market. Insulet suffered from defective controls over its manufacturing processes. The Company faced increased risks of safety violations due to these deficiencies. The Company's manufacturing problem necessitating its March 2026 Medical Device Cirrection impacted a greater number of its Pod Products than it claimed. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Insulet, investors suffered damages.
We encourage investors to contact Brian Schall and David Schwartz of Schall Brown & Schwartz, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
Join the case to recover your losses
Why SBS: Schall Brown & Schwartz represents investors around the world, specializing in securities class action lawsuits and shareholder rights litigation. SBS brings together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz. SBS attorneys and their co-counsel are responsible for recovering over a billion dollars for violations of securities laws and corporate misfeasance.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
Schall Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]
SOURCE Schall, Brown & Schwartz LLP

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。